WallStreetZenWallStreetZen

NASDAQ: SGMO
Sangamo Therapeutics Inc Stock Ownership - Who owns Sangamo Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Sangamo Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Scott B. WilloughbySVP CHIEF LEGAL OFFICER SECY2026-02-2512,354$0.47
$5.81kSell
Nikunj JainPrincipal Accounting Officer2026-02-255,119$0.47
$2.41kSell
Sandy MacRaePRESIDENT CEO AND DIRECTOR2026-02-2533,637$0.47
$15.81kSell
Gregory D. DavisHead of Research Technology2026-02-255,119$0.47
$2.41kSell
Nathalie DuboisstringfellowSVP-CHIEF DEVELOPMENT OFFICER2026-02-2512,354$0.47
$5.81kSell
Nikunj JainPrincipal Accounting Officer2026-02-24666$0.47
$314.35Sell
Nathalie DuboisstringfellowSVP-CHIEF DEVELOPMENT OFFICER2026-02-242,063$0.47
$973.74Sell
Scott B. WilloughbySVP CHIEF LEGAL OFFICER SECY2026-02-241,650$0.47
$778.80Sell
Sandy MacRaePRESIDENT CEO AND DIRECTOR2026-02-245,291$0.47
$2.50kSell
Gregory D. DavisHead of Research Technology2026-02-24832$0.47
$392.70Sell

1 of 5

SGMO insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when SGMO insiders and whales buy or sell their stock.

SGMO Shareholders

What type of owners hold Sangamo Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Biogen Inc5.25%17,652,466$6.71MInsider
Vanguard Group Inc3.57%12,000,383$4.56MInstitution
Renaissance Technologies LLC2.51%8,430,323$3.20MInstitution
Two Sigma Investments LP1.41%4,755,995$1.81MInstitution
Blackrock Inc1.36%4,571,786$1.74MInstitution
Two Sigma Advisers LP1.29%4,343,255$1.65MInstitution
Geode Capital Management LLC1.15%3,866,026$1.47MInstitution
Ra Capital Management LP1.09%3,683,002$1.40MInsider
Jane Street Group LLC0.87%2,918,127$1.11MInstitution
Susquehanna International Group LLP0.64%2,137,120$812.11kInstitution

1 of 3

SGMO vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
SGMO18.50%9.46%Net SellingNet Selling
CNTN23.04%15.90%Net Buying
FATE51.23%48.77%Net SellingNet Selling
CRDF39.86%25.66%Net Buying
BDTX65.20%34.80%Net Buying
View Top Biotech Stocks

Sangamo Therapeutics Stock Ownership FAQ

Who owns Sangamo Therapeutics?

Sangamo Therapeutics (NASDAQ: SGMO) is owned by 18.50% institutional shareholders, 9.46% Sangamo Therapeutics insiders, and 72.04% retail investors. Biogen Inc is the largest individual Sangamo Therapeutics shareholder, owning 17.65M shares representing 5.25% of the company. Biogen Inc's Sangamo Therapeutics shares are currently valued at $6.35M.

If you're new to stock investing, here's how to buy Sangamo Therapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.